• HOME
  • QUIZ
  • CONTACT US
EXAMIANS
  • COMPUTER
  • CURRENT AFFAIRS
  • ENGINEERING
    • Chemical Engineering
    • Civil Engineering
    • Computer Engineering
    • Electrical Engineering
    • Mechanical Engineering
  • ENGLISH GRAMMAR
  • GK
  • GUJARATI MCQ

Current Affairs - July 2020

Current Affairs - July 2020
The National Task Force on COVID-19 recently decided against using which drug in clinical management protocols?

Itolizumab
Favilavir
Chloroquine
Fusogenix

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
In accordance with "3rd edition of The Global E-waste Monitor 2020 report-Quantities, flows, and the circular economy potential" report, the world dumped a how much million tonnes of e-waste in 2019?

43.6
53.6
33.6
23.6

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Indian Railways is planning to radio-frequency identification tags (RFID) Tag all wagons by the end of which year?

2022
2019
2021
2020

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Who has been appointed as the new MD of Karur Vysya Bank?

Rekha Malik
P R Seshadri
N. S. Srinath
Ramesh Babu Boddu

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Union Cabinet has given its approval to a 10 years long (FY2020 to FY2029) pan India Central Sector Scheme namely "Agriculture Infrastructure Fund" with how much outlay?

Rs. 4 Lakh Crore
Rs. 1 Lakh Crore
Rs. 3 Lakh Crore
Rs. 2 Lakh Crore

ANSWER DOWNLOAD EXAMIANS APP

Current Affairs - July 2020
Which organization recently released the title 'Active Pharmaceutical Ingredients- Status, Issues, Technology Readiness, and Challenges'?

TIFAC
CBFC
ISRO
SEBI

ANSWER DOWNLOAD EXAMIANS APP
MORE MCQ ON Current Affairs - July 2020

DOWNLOAD APP

  • APPLE
    from app store
  • ANDROID
    from play store

SEARCH

LOGIN HERE


  • GOOGLE

FIND US

  • 1.70K
    FOLLOW US
  • EXAMIANSSTUDY FOR YOUR DREAMS.
  • SUPPORT :SUPPORT EMAIL ACCOUNT : examians@yahoo.com

OTHER WEBSITES

  • GUJARATI MCQ
  • ACCOUNTIANS

QUICK LINKS

  • HOME
  • QUIZ
  • PRIVACY POLICY
  • DISCLAIMER
  • TERMS & CONDITIONS
  • CONTACT US
↑